Approval · Notice of Compliance 36349 · 2025
ALDACTONE: Notice of Compliance 36349
Issued November 7, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36349
- Date
- November 7, 2025
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDACTONE | Not yet assigned | — |
Medicinal ingredients
- SPIRONOLACTONE 25 MG per TAB
- SPIRONOLACTONE 100 MG per TAB